Healthcare Finance News November 6, 2023
Jeff Lagasse

Lawmakers are concerned that CMS’ 2024 final Part C and D rule may not adequately address MA plans’ increased reliance on AI.

Democratic lawmakers in the U.S. House of Representatives have penned a letter to the Centers for Medicare and Medicaid Services, asking the federal agency to analyze artificial intelligence use in Medicare Advantage plans with an eye toward reducing claims denial rates.

In particular, representatives are concerned that CMS’ 2024 final Part C and D rule, which establishes new prior authorization requirements, may not adequately address MA plans’ increased reliance on artificial intelligence to guide coverage decisions.

Most items and services in traditional Medicare are not subject to prior authorization and instead are submitted to Medicare Administrative Contractors...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), CMS, Congress / White House, Govt Agencies, Insurance, Medicare Advantage, Provider, Technology
Growth in Medicare Advantage Raises Concerns
Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs
CMS proposes $21B payment increase for Medicare Advantage in 2026: 10 notes
Medicare Advantage leads to lower cancer drug costs in colorectal cancer
A Stronger Medicare Program—Now And Into The Future

Share This Article